US 4,283,349 AGranted

Novel oxiodinium and thiaiodinium compounds

AssigneeEli Lilly and Company

InventorWilliam N. Cannon

Life of this patent

Estimating the term…

Abstract

Novel oxiodinium and thiaiodinium compounds having a superior inhibitory effect against micro-organisms coupled with outstanding stability and low toxicity are described.

Claims2

Dependent claims

The compound dibenz[be][1,4]oxiodinium 3,4-dichlorobenzene sulfonate.

Dependencies are inferred from the claim text.

Facts

Application: 06/041,283Filed 21 May 1979 · division
Priority: 4 Apr 1963
Granted: 11 Aug 1981
Term ends: Not estimatedThe source records don’t support an estimate.

Classification2 codes

C07D 347/00
Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms
C07D
Heterocyclic compounds

Family

Serial270,545Parent of this continuation-in-part · filed 4 Apr 1963
Serial654,656Parent of this continuation-in-part · filed 19 Jul 1967
Serial16,589Parent of this continuation-in-part · filed 4 Mar 1970
Serial337,345Parent of this division · filed 2 Mar 1973
US 4,193,935 AParent of this division
3506719Parent of this continuation-in-part
US 4,283,349 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…